iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionWebster Bank, N. A.
Latest Disclosed Ownership6,466 shares
Latest Disclosed Value $ 1,091,784
Webster Bank, N. A. reports 0.15% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 17, 2026 - Webster Bank, N. A. filed a 13F-HR form disclosing ownership of 6,466 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $1,091,784 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 6,476 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -0.15% during the quarter. The current value of the position is $847,369 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,466 -10 -0.15 1,092 -0.09 0.1034
2026-01-23 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,476 62 0.97 1,093 18.05 0.1025
2025-10-23 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,414 0 0.00 926 14.06 0.0891
2025-07-08 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 6,414 0 0.00 811 -1.10 0.0838
2025-04-04 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 6,414 0 0.00 820 -3.19 0.0902
2025-01-22 2024-12-31 13F ISHARES ISHARES BIOTECH 464287556 6,414 -650 -9.20 848 -17.61 0.0911
2024-10-10 2024-09-30 13F ISHARES ISHARES BIOTECH 464287556 7,064 -250 -3.42 1,029 2.49 0.1094
2024-07-12 2024-06-30 13F ISHARES ISHARES BIOTECH 464287556 7,314 0 0.00 1,004 0.00 0.1101
2024-04-16 2024-03-31 13F ISHARES ISHARES BIOTECH 464287556 7,314 -527 -6.72 1,004 -5.82 0.1121
2024-01-23 2023-12-31 13F ISHARES ISHARES BIOTECH 464287556 7,841 0 0.00 1,065 11.17 0.1304
2023-10-10 2023-09-30 13F ISHARES ISHARES BIOTECH 464287556 7,841 0 0.00 959 -3.72 0.1297
2023-07-13 2023-06-30 13F ISHARES ISHARES BIOTECH 464287556 7,841 -480 -5.77 995 -7.36 0.1286
2023-04-13 2023-03-31 13F ISHARES ISHARES BIOTECH 464287556 8,321 -450 -5.13 1,075 107,300.00 0.1401
2023-01-18 2022-12-31 13F ISHARES ISHARES BIOTECH 464287556 8,771 0 0.00 1 -99.90 0.1557
2022-10-24 2022-09-30 13F ISHARES ISHARES BIOTECH 464287556 8,771 -400 -4.36 1,026 -4.91 0.1487
2022-07-12 2022-06-30 13F ISHARES ISHARES BIOTECH 464287556 9,171 -8,931 -49.34 1,079 -54.24 0.1473
2022-04-13 2022-03-31 13F ISHARES ISHARES BIOTECH 464287556 18,102 8,551 89.53 2,358 61.73 0.1692
2022-01-12 2021-12-31 13F ISHARES ISHARES BIOTECH 464287556 9,551 0 0.00 1,458 -5.63 0.1510
2021-10-12 2021-09-30 13F ISHARES ISHARES BIOTECH 464287556 9,551 180 1.92 1,545 0.78 0.1725
2021-07-20 2021-06-30 13F ISHARES NASDAQ BIOTECH 464287556 9,371 0 0.00 1,533 8.65 0.1677
2021-05-07 2021-03-31 13F ISHARES NASDAQ BIOTECH 464287556 9,371 -313 -3.23 1,411 -3.82 0.1607
2021-01-07 2020-12-31 13F ISHARES NASDAQ BIOTECH 464287556 9,684 -2 -0.02 1,467 11.81 0.1724
2020-10-22 2020-09-30 13F ISHARES NASDAQ BIOTECH 464287556 9,686 -200 -2.02 1,312 -2.89 0.1722
2020-07-09 2020-06-30 13F ISHARES NASDAQ BIOTECH 464287556 9,886 -225 -2.23 1,351 23.94 0.1916
2020-04-21 2020-03-31 13F ISHARES NASDAQ BIOTECH 464287556 10,111 -1,020 -9.16 1,090 -18.72 0.1812
2020-01-14 2019-12-31 13F ISHARES NASDAQ BIOTECH 464287556 11,131 -885 -7.37 1,341 12.22 0.1713
2019-10-01 2019-09-30 13F ISHARES NASDAQ BIOTECH 464287556 12,016 -3,700 -23.54 1,195 -30.28 0.1618
2019-07-11 2019-06-30 13F ISHARES NASDAQ BIOTECH 464287556 15,716 -200 -1.26 1,714 -3.65 0.2360
2019-04-10 2019-03-31 13F ISHARES NASDAQ BIOTECH 464287556 15,916 -200 -1.24 1,779 14.48 0.2543
2019-01-09 2018-12-31 13F ISHARES NASDAQ BIOTECH 464287556 16,116 -900 -5.29 1,554 -25.07 0.2509
2018-10-12 2018-09-30 13F ISHARES NASDAQ BIOTECH 464287556 17,016 -1,350 -7.35 2,074 2.83 0.2890
2018-07-12 2018-06-30 13F ISHARES NASDAQ BIOTECH 464287556 18,366 0 0.00 2,017 2.86 0.2914
2018-04-19 2018-03-31 13F ISHARES NASDAQ BIOTECH 464287556 18,366 -270 -1.45 1,961 -1.46 0.2831
2018-01-23 2017-12-31 13F ISHARES NASDAQ BIOTECH 464287556 18,636 12,174 188.39 1,990 -7.70 0.2737
2017-10-12 2017-09-30 13F ISHARES NASDQ BIOTEC ETF 464287556 6,462 -110 -1.67 2,156 5.79 0.3134
2017-07-12 2017-06-30 13F BlackRock Fund Advisors NASDQ BIOTEC ETF 464287556 6,572 -40 -0.60 2,038 5.11 0.3017
2017-05-01 2017-03-31 13F BlackRock Fund Advisors NASDQ BIOTEC ETF 464287556 6,612 -313 -4.52 1,939 5.55 0.2924
2017-02-15 2016-12-31 13F BlackRock Fund Advisors NASDQ BIOTEC ETF 464287556 6,925 -74 -1.06 1,837 -9.33 0.2686
2016-10-14 2016-09-30 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 6,999 -295 -4.04 2,026 7.94 0.2948
2016-07-11 2016-06-30 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 7,294 -255 -3.38 1,877 -4.67 0.2752
2016-04-12 2016-03-31 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 7,549 -393 -4.95 1,969 -26.72 0.3074
2016-01-13 2015-12-31 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 7,942 -400 -4.80 2,687 6.21 0.4312
2015-11-12 2015-09-30 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 8,342 -327 -3.77 2,530 -20.91 0.4661
2015-07-09 2015-06-30 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 8,669 -259 -2.90 3,199 4.34 0.5355
2015-04-30 2015-03-31 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 8,928 -350 -3.77 3,066 8.96 0.5068
2015-01-15 2014-12-31 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 9,278 -757 -7.54 2,814 2.48 0.4720
2014-10-15 2014-09-30 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 10,035 -7,391 -42.41 2,746 -38.69 0.4855
2014-07-09 2014-06-30 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 17,426 -5,176 -22.90 4,479 -16.17 0.7729
2014-04-11 2014-03-31 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 22,602 58 0.26 5,343 4.38 0.7381
2014-01-28 2013-12-31 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 22,544 -40 -0.18 5,119 8.16 0.7165
2013-11-05 2013-09-30 13F ISHARES NASDAQ BIOTECH ETF COMMON STOCK 464287556 22,584 1,235 5.78 4,733 27.51 0.7286
2013-08-06 2013-06-30 13F ISHARES NASDAQ BIOTECH INDX COMMON STOCK 464287556 21,349 21,349 3,712 0.4682
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.